Suppliers / Authenterra Healthcare

Authenterra Healthcare

India Updated 9 July 2026

Authenterra Healthcare is an API manufacturer based in India. It holds 6 active US drug master files across a filed portfolio of 6 molecules.

6
active US DMFs
0
valid CEPs
0
registered plants
0
filings across 0 regulators

What they file, and where

Molecule Regulators Docs
Amitraz US FDA 1
Flunixin US FDA 1
Mannitol US FDA 1
Marbofloxacin US FDA 1
Praziquantel US FDA 1
Triclabendazole US FDA 1

Also appears on these molecule pages

Praziquantel API

Questions about Authenterra Healthcare

Does Authenterra Healthcare hold a US DMF or a CEP?
Authenterra Healthcare holds 6 active US drug master files. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
What does Authenterra Healthcare make?
6 molecules are on record against Authenterra Healthcare, including Amitraz, Flunixin, Mannitol and Marbofloxacin. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Authenterra Healthcare comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Cipla shares 1 molecule Micro Labs shares 1 molecule Solara Active Pharma Sciences shares 1 molecule Chromo Laboratories India shares 1 molecule Shanghai Desano Chemical Pharmaceutical shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability